Panacea Biotec informs about press release

10 Jun 2020 Evaluate

Panacea Biotec has informed  that the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing and distribution of the Covid-19 vaccine. Under the collaboration, the company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make Covid-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland.  The company has informed that it has enclosed a copy of the Press Release on 10th June 2020 titled ‘Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine’ being issued to the media.

The above information is a part of company’s filings submitted to BSE.


Panacea Biotec Share Price

563.45 -0.20 (-0.04%)
30-Apr-2025 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.65
Dr. Reddys Lab 1183.10
Cipla 1551.95
Lupin 2096.30
Zydus Lifesciences 891.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...